Primary and secondary osteoporosis in men and biochemical markers of bone metabolism

Marcelo Sarli(Universidad del Salvador), José Zanchetta(Universidad del Salvador), Horacio Plotkin(Instituto de Diagnóstico e Investigaciones Metabólicas)

Osteoporosis International

January 1, 1996

10.1007/bf02500661

Cited by 0

Related Papers

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

|New England Journal of Medicine|2001|4.6k

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

|New England Journal of Medicine|2009|3.5k

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

|New England Journal of Medicine|2014|1.2k

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

|Journal of Bone and Mineral Research|2008|508

Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial

|Arthritis & Rheumatism|2009|497